Arena Life Science


Generic name: Rivaroxaban

Pharmacologic Category: Anticoagulant

Dosage Forms: Oral Film-coated tablets, 10-15-20 mg


Rivaroxaban is a highly selective direct factor Xa inhibitor with high oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi.


  • Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation (NVAF)
  • Treatment of deep vein thrombosis (DVT)
  • Treatment of pulmonary embolism (PE)
  • Reduction in the risk of recurrence of DVT or PE  
  • Prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
  • Prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients
  • Axabin® is the first generic form of rivaroxaban in Iran which is produced at a GMP approved manufacturing site

Did you know, if you have AFib not caused by a heart valve problem, you are 5x more likely to have a stroke?

Did you know, worldwide VTE attack rates are estimated from 142 to more than 300 per 100,000 person-years and estimated attack rates for DVT and PE are 91–255 and 51–75 per 100,000 person-years, respectively?


Product images
  • Rivaroxaban (Axabin® 10,15,20)
  • Rivaroxaban (Axabin® 10,15,20)
  • Rivaroxaban (Axabin® 10,15,20)
  • Rivaroxaban (Axabin® 10,15,20)
Product sharing
Related products
Click + to add content

Company Address

No 20, 5th Floor , 8th Sharestan , Makoueipour St, Za'feraniyeh, Tehran-Iran

Phone: (+98) 21 26 80 5483 - 21 26 80 5489 - Fax: (+98)21 26 80 5478     Email: